Figure 1: The NOSC’s agreed clinical pathway for the diagnosis and treatment of patients with glioma. Early diagnosis, history, clinical examination, neuroimaging, preoperative management, biopsy and resection, histological classification and grading, molecular diagnostics as well as surgical therapy, radiotherapy, pharmacotherapy, and other therapeutic approaches are considered in the pathway. The pathways would be expected to receive updates in coming years when molecular markers testing set-up and novel therapies become widely accessible in our setting.